Skip to main content
Erschienen in:

25.01.2022 | Original Paper

Do we care about high-cost patients? Estimating the savings on health spending by integrated care

verfasst von: Karen Geurts, Marc Bruijnzeels, Erik Schokkaert

Erschienen in: The European Journal of Health Economics | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

A recent integrated health care initiative in Belgium supports 12 regional pilot projects scattered across the country and representing 21% of the population. As in shared savings programs, part of the estimated savings in health spending are paid out to the projects to reinvest in new actions. Short-term savings are expected in particular from cost reductions among high-cost patients. We estimate the effect of the projects on spending using a difference-in-difference model. The sensitivity of the results to the right-skewness of spending is commonly addressed by removing or top-coding high-cost cases. However, this leads to an underestimation of realized savings at the top end of the distribution, therefore, lowering incentives for cost reduction. We show that this trade-off can be weakened by an alternative approach in which cost categories that fall out of the scope of the projects’ interventions are excluded from the dependent variable. We find that this approach leads to improvements in precision and model fit that are of the same magnitude as excluding high-cost cases altogether. At the same time, it sharpens the incentives for cost reduction because the model better reflects the costs that projects can affect.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
The subsidy corresponds to the salary of one full-time employee plus overhead.
 
2
Some examples of these interventions are: avoiding duplication of services, e.g. of blood sample or medical images; preventive interventions such as fall prevention in the elderly; follow-up care such as after patients’ discharge from a hospital; patient self-management such as medication schedules.
 
3
Because the estimations did not yield significant results, payments based on savings have been suspended for the first two years of the program (2018–2019).
 
4
The downside of this approach is that individuals who move to another region, transfer previous incentives that might affect health care use to another group. Another approach used in some evaluations is to limit the sample to the cohort that can be assigned to a particular group over the entire period of analysis. However, over an 8-year pre- and postintervention period, this would lead to a high percentage of exclusions, including an important target group of integrated care interventions, in particular older persons who die before the end of the evaluation period.
 
5
In addition to reimbursed and out-of-pocket payments, there are also supplements. Supplements are the difference between the actual rate and the conventional rate for services included in the compulsory health insurance system, or for the full price for care services not included in that system. Supplements in hospitals are regulated to a certain extent, but in the ambulatory sector providers have a large degree of freedom to determine them.
 
6
The mean absolute error avoids the disadvantage of R-square type measures that outliers are heavily weighted.
 
7
As an instrument to control hospital drugs costs, medication during hospital stays is reimbursed on the basis of a fixed payment per patient-day (per diem). However, a number of mostly expensive and/or innovative drugs are reimbursed on a fee-for-service basis. These drugs are defined by their active substance (5th level of ATC classification).
 
8
The values of the 99.9th and 99th percentile are about 19 and 11 times the mean cost.
 
Literatur
2.
Zurück zum Zitat Wagner, E., Austin, B., Von Korff, M.: Organizing care for patients with chronic illness. Milbank Q. 74(4), 511–544 (1996)CrossRef Wagner, E., Austin, B., Von Korff, M.: Organizing care for patients with chronic illness. Milbank Q. 74(4), 511–544 (1996)CrossRef
3.
Zurück zum Zitat Paulus, D., Van den Heede, K., Mertens R.: Position paper: organisatie van zorg voor chronisch zieken in België. Brussels, KCE Report 190A (2012) Paulus, D., Van den Heede, K., Mertens R.: Position paper: organisatie van zorg voor chronisch zieken in België. Brussels, KCE Report 190A (2012)
9.
Zurück zum Zitat Peckham, A., Rudoler, D., Allin, S., Bhatia, D., Abdelhalim, R., Kavelaars, R.A., Marchildon, G.: Accountable care organizations: success factors, provider perspectives and an appraisal of the evidence. North American Observatory on Health Systems and Policies, Toronto. Rapid review (no. 12) (2019) Peckham, A., Rudoler, D., Allin, S., Bhatia, D., Abdelhalim, R., Kavelaars, R.A., Marchildon, G.: Accountable care organizations: success factors, provider perspectives and an appraisal of the evidence. North American Observatory on Health Systems and Policies, Toronto. Rapid review (no. 12) (2019)
15.
Zurück zum Zitat McGuire, T.G., van Kleef, R.C.: Risk sharing. In: McGuire, T.G., van Kleef, R.C. (eds.) Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets: Theory and Practice, pp. 105–132. Academic Press, Cambridge (2018)CrossRef McGuire, T.G., van Kleef, R.C.: Risk sharing. In: McGuire, T.G., van Kleef, R.C. (eds.) Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets: Theory and Practice, pp. 105–132. Academic Press, Cambridge (2018)CrossRef
16.
Zurück zum Zitat Jones, A.M.: Models for health care. In: Clement, M.P., Hendry, D.F. (eds.) The Oxford Handbook of Economic Forecasting. Oxford University Press, Oxford (2011) Jones, A.M.: Models for health care. In: Clement, M.P., Hendry, D.F. (eds.) The Oxford Handbook of Economic Forecasting. Oxford University Press, Oxford (2011)
17.
Zurück zum Zitat Ellis, R.P., Martins, B., Sherri, R.: Risk adjustment for health plan payment. In: McGuire, T.G., van Kleef, R.C. (eds.) Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets: Theory and Practice, pp. 55–104. Academic Press, Cambridge (2018)CrossRef Ellis, R.P., Martins, B., Sherri, R.: Risk adjustment for health plan payment. In: McGuire, T.G., van Kleef, R.C. (eds.) Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets: Theory and Practice, pp. 55–104. Academic Press, Cambridge (2018)CrossRef
20.
Zurück zum Zitat Angrist, J.D., Pischke, J.S.: Mostly Harmless Econometrics. An Empiricist’s Companion. Princeton University Press, Princeton (2009)CrossRef Angrist, J.D., Pischke, J.S.: Mostly Harmless Econometrics. An Empiricist’s Companion. Princeton University Press, Princeton (2009)CrossRef
21.
Zurück zum Zitat Wooldridge, J.: Econometric Analysis of Cross Section and Panel Data. MIT Press, Cambridge (2001) Wooldridge, J.: Econometric Analysis of Cross Section and Panel Data. MIT Press, Cambridge (2001)
22.
Zurück zum Zitat Schokkaert, E., Guillaume, J., van de Voorde, C.: Risk adjustment in Belgium: why and how to introduce socioeconomic variables in health plan payment. In: McGuire, T.G., van Kleef, R.C. (eds.) Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets: Theory and Practice, pp. 209–232. Academic Press, Cambridge (2018)CrossRef Schokkaert, E., Guillaume, J., van de Voorde, C.: Risk adjustment in Belgium: why and how to introduce socioeconomic variables in health plan payment. In: McGuire, T.G., van Kleef, R.C. (eds.) Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets: Theory and Practice, pp. 209–232. Academic Press, Cambridge (2018)CrossRef
Metadaten
Titel
Do we care about high-cost patients? Estimating the savings on health spending by integrated care
verfasst von
Karen Geurts
Marc Bruijnzeels
Erik Schokkaert
Publikationsdatum
25.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
The European Journal of Health Economics / Ausgabe 8/2022
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-022-01431-3